Intra-articular hylastan versus steroid for knee osteoarthritis

[1]  F. Cicuttini,et al.  Effects of Hylan G-F 20 supplementation on cartilage preservation detected by magnetic resonance imaging in osteoarthritis of the knee: a two-year single-blind clinical trial , 2011, BMC musculoskeletal disorders.

[2]  José A. Rodriguez,et al.  Intra-articular hip injection: does pain relief correlate with radiographic severity of osteoarthritis? , 2011, Skeletal Radiology.

[3]  A. Spitzer,et al.  Hylan G-F 20 Improves Hip Osteoarthritis: A Prospective, Randomized Study , 2010, The Physician and sportsmedicine.

[4]  P Tugwell,et al.  OARSI recommendations for the management of hip and knee osteoarthritis: part III: Changes in evidence following systematic cumulative update of research published through January 2009. , 2010, Osteoarthritis and cartilage.

[5]  R. Altman.  Early management of osteoarthritis. , 2010, The American journal of managed care.

[6]  Raveendhara R. Bannuru,et al.  Therapeutic trajectory of hyaluronic acid versus corticosteroids in the treatment of knee osteoarthritis: a systematic review and meta-analysis. , 2009, Arthritis and rheumatism.

[7]  R. Altman.  Practical considerations for the pharmacologic management of osteoarthritis. , 2009, The American journal of managed care.

[8]  R. Moskowitz.  The burden of osteoarthritis: clinical and quality-of-life issues. , 2009, The American journal of managed care.

[9]  K. Kalunian,et al.  Inflammatory Characteristics on Ultrasound Predict Poorer Longterm Response to Intraarticular Corticosteroid Injections in Knee Osteoarthritis , 2009, The Journal of Rheumatology.

[10]  J. Niinimäki,et al.  Disability in end-stage knee osteoarthritis , 2009, Disability and rehabilitation.

[11]  K. Jordan,et al.  A randomised controlled trial of tidal irrigation vs corticosteroid injection in knee osteoarthritis: the KIVIS Study. , 2008, Osteoarthritis and cartilage.

[12]  Johanne Martel-Pelletier,et al.  Cartilage in normal and osteoarthritis conditions. , 2008, Best practice & research. Clinical rheumatology.

[13]  P Tugwell,et al.  OARSI recommendations for the management of hip and knee osteoarthritis, Part II: OARSI evidence-based, expert consensus guidelines. , 2008, Osteoarthritis and cartilage.

[14]  A. Pendleton,et al.  Can sonography be used to predict the response to intra‐articular corticosteroid injection in primary osteoarthritis of the knee? , 2008, Scandinavian journal of rheumatology.

[15]  A. Klovning,et al.  Short‐term efficacy of pharmacotherapeutic interventions in osteoarthritic knee pain: A meta‐analysis of randomised placebo‐controlled trials , 2007, European journal of pain.

[16]  S. Goldring,et al.  Clinical aspects, pathology and pathophysiology of osteoarthritis. , 2006, Journal of musculoskeletal & neuronal interactions.

[17]  P. Conaghan,et al.  Clinical effectiveness and dose response of image-guided intra-articular corticosteroid injection for hip osteoarthritis. , 2006, Rheumatology.

[18]  L. March,et al.  Longterm effects of intraarticular hyaluronan on synovial fluid in osteoarthritis of the knee. , 2006, The Journal of rheumatology.

[19]  N. Bellamy,et al.  Viscosupplementation for the treatment of osteoarthritis of the knee. , 2006, The Cochrane database of systematic reviews.

[20]  J. Raynauld,et al.  Most recent developments in strategies to reduce the progression of structural changes in osteoarthritis: today and tomorrow , 2006, Arthritis research & therapy.

[21]  F. Blanco,et al.  The biological action of hyaluronan on human osteoartritic articular chondrocytes: the importance of molecular weight. , 2004, Clinical and experimental rheumatology.

[22]  M. Dougados,et al.  OMERACT-OARSI initiative: Osteoarthritis Research Society International set of responder criteria for osteoarthritis clinical trials revisited. , 2004, Osteoarthritis and cartilage.

[23]  B. Arroll,et al.  Corticosteroid injections for osteoarthritis of the knee: meta-analysis , 2004, BMJ : British Medical Journal.

[24]  D. Pyne,et al.  Intra-articular steroids in knee osteoarthritis: a comparative study of triamcinolone hexacetonide and methylprednisolone acetate , 2004, Clinical Rheumatology.

[25]  D. Caborn,et al.  A randomized, single-blind comparison of the efficacy and tolerability of hylan G-F 20 and triamcinolone hexacetonide in patients with osteoarthritis of the knee. , 2004, The Journal of rheumatology.

[26]  Arden,et al.  EULAR Recommendations 2003: an evidence based approach to the management of knee osteoarthritis: Report of a Task Force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT) , 2003, Annals of the rheumatic diseases.

[27]  M. Dougados,et al.  Outcome variables for osteoarthritis clinical trials: The OMERACT-OARSI set of responder criteria. , 2003, The Journal of rheumatology.

[28]  D. Guidolin,et al.  Morphological analysis of articular cartilage biopsies from a randomized, clinical study comparing the effects of 500-730 kDa sodium hyaluronate (Hyalgan) and methylprednisolone acetate on primary osteoarthritis of the knee. , 2001, Osteoarthritis and cartilage.

[29]  G. Bergamini,et al.  Morphological analysis of knee synovial membrane biopsies from a randomized controlled clinical study comparing the effects of sodium hyaluronate (Hyalgan) and methylprednisolone acetate (Depomedrol) in osteoarthritis. , 2001, Rheumatology.

[30]  P. Bacchini,et al.  Intra-articular hyaluronic acid in the treatment of osteoarthritis of the knee: clinical and morphological study. , 1998, Clinical and experimental rheumatology.

[31]  M. Dougados,et al.  Arthroscopic evaluation of potential structure modifying activity of hyaluronan (Hyalgan) in osteoarthritis of the knee. , 1997, Osteoarthritis and cartilage.

[32]  A. Jones,et al.  Intra-articular corticosteroids are effective in osteoarthritis but there are no clinical predictors of response. , 1996, Annals of the rheumatic diseases.

[33]  J. D. Perry,et al.  Intra-articular triamcinolone hexacetonide in knee osteoarthritis: factors influencing the clinical response. , 1995, Annals of the rheumatic diseases.

[34]  M. Regan,et al.  Importance of placement of intra-articular steroid injections. , 1993, BMJ.

[35]  J. Martel-Pelletier,et al.  The pathophysiology of osteoarthritis and the implication of the use of hyaluronan and hylan as therapeutic agents in viscosupplementation. , 1993, The Journal of rheumatology. Supplement.

[36]  R. Moskowitz,et al.  Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Association. , 1986, Arthritis and rheumatism.

[37]  J. Pelletier,et al.  DMOAD developments: present and future. , 2007, Bulletin of the NYU hospital for joint diseases.

[38]  N. Bellamy,et al.  Intraarticular corticosteroid for treatment of osteoarthritis of the knee. , 2005, The Cochrane database of systematic reviews.

[39]  Thomas J. Schnitzer,et al.  Recommendations for the medical management of osteoarthritis of the hip and knee: 2000 update , 2000 .